Last reviewed · How we verify

Ambulatory Oxygen

Royal Brompton & Harefield NHS Foundation Trust · FDA-approved active Small molecule Quality 5/100

Ambulatory Oxygen is a Small molecule drug developed by Royal Brompton & Harefield NHS Foundation Trust. It is currently FDA-approved. Also known as: portable oxygen cylinders, light weight oxygen cylinders.

At a glance

Generic nameAmbulatory Oxygen
Also known asportable oxygen cylinders, light weight oxygen cylinders
SponsorRoyal Brompton & Harefield NHS Foundation Trust
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Ambulatory Oxygen

What is Ambulatory Oxygen?

Ambulatory Oxygen is a Small molecule drug developed by Royal Brompton & Harefield NHS Foundation Trust.

Who makes Ambulatory Oxygen?

Ambulatory Oxygen is developed and marketed by Royal Brompton & Harefield NHS Foundation Trust (see full Royal Brompton & Harefield NHS Foundation Trust pipeline at /company/royal-brompton-harefield-nhs-foundation-trust).

Is Ambulatory Oxygen also known as anything else?

Ambulatory Oxygen is also known as portable oxygen cylinders, light weight oxygen cylinders.

What development phase is Ambulatory Oxygen in?

Ambulatory Oxygen is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing